H
Halozyme Therapeutics, Inc. (HALO)
NMS – Real Time Price. Currency in USD
74.96
+2.33 (3.20%)
At close: Jun 26, 2026, 4:00 PM EDT
75.00
+0.04 (0.05%)
After-hours: Jun 26, 2026, 7:28 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
74.96
+2.33 (3.20%)
At close: Jun 26, 2026, 4:00 PM EDT
75.00
+0.04 (0.05%)
After-hours: Jun 26, 2026, 7:28 PM EDT
| Breakdown | |
|---|---|
| 1.07% | % of Shares Held by All Insider |
| 107.20% | % of Shares Held by Institutions |
| 108.36% | % of Float Held by Institutions |
| 880 | Number of Institutions Holding Shares |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Blackrock Inc. | 13.27M | 2026-03-31 | 11.18% | $1.01B |
| Vanguard Capital Management LLC | 5.27M | 2026-03-31 | 4.44% | $401.14M |
| Vanguard Portfolio Management LLC | 5.25M | 2026-03-31 | 4.43% | $399.46M |
| State Street Corporation | 4.94M | 2026-03-31 | 4.16% | $375.77M |
| Invesco Ltd. | 4.01M | 2026-03-31 | 3.38% | $305.35M |
| Bank of America Corporation | 2.91M | 2026-03-31 | 2.46% | $221.69M |
| Boston Partners | 2.68M | 2026-03-31 | 2.26% | $204.23M |
| Morgan Stanley | 2.56M | 2026-03-31 | 2.16% | $194.99M |
| William Blair Investment Management, LLC | 2.53M | 2026-03-31 | 2.13% | $192.23M |
| Geode Capital Management, LLC | 2.51M | 2026-03-31 | 2.11% | $190.69M |
| Dimensional Fund Advisors LP | 2.08M | 2026-03-31 | 1.76% | $133.36M |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.99M | 2026-05-31 | 3.36% | $303.59M |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.74M | 2026-03-31 | 3.15% | $284.34M |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.72M | 2026-03-31 | 2.29% | $207.07M |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.52M | 2026-03-31 | 1.29% | $116.01M |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.43M | 2026-04-30 | 1.20% | $108.63M |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.41M | 2026-05-31 | 1.19% | $107.36M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.31M | 2026-03-31 | 1.11% | $99.92M |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 1.14M | 2026-05-31 | 0.96% | $86.68M |
| Vanguard Explorer Fund | 1.09M | 2026-01-31 | 0.92% | $83.32M |
| AIM Counselor Series TRT -Invesco Discovery Fd. | 1.05M | 2026-02-28 | 0.88% | $79.68M |
| SPDR S&P MIDCAP 400 ETF TRT-State Street SPDR S&P Mid Cap 400 ETF TRT | 886,341 | 2026-03-31 | 0.75% | $56.00M |
| SPDR S&P MIDCAP 400 ETF TRUST | 883,662 | 2025-12-31 | 0.75% | $59.92M |
| iShares Trust-iShares Biotechnology ETF | 869,719 | 2026-02-28 | 0.73% | $60.51M |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Growth Fund | 854,255 | 2025-12-31 | 0.72% | $55.09M |